应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09969 诺诚健华
已收盘 07-28 16:09:12
18.200
+0.460
+2.59%
最高
18.360
最低
17.300
成交量
1,530万
今开
17.800
昨收
17.740
日振幅
5.98%
总市值
320.87亿
流通市值
272.09亿
总股本
17.63亿
成交额
2.73亿
换手率
1.02%
流通股本
14.95亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
诺诚健华07月24日主力净流入228.3万元 散户资金抛售
市场透视 · 07-24
诺诚健华07月24日主力净流入228.3万元 散户资金抛售
诺诚健华07月23日主力净流出319.8万元 散户资金买入
市场透视 · 07-23
诺诚健华07月23日主力净流出319.8万元 散户资金买入
券商资管系公募,排名来了!
中国基金报 · 07-22
券商资管系公募,排名来了!
诺诚健华07月22日获主力加仓70.3万元
市场透视 · 07-22
诺诚健华07月22日获主力加仓70.3万元
港股创新药板块异动拉升 丽珠医药涨超12%
E公司 · 07-22
港股创新药板块异动拉升 丽珠医药涨超12%
公募基金2025年二季报全扫描【国信金工】
量化藏经阁 · 07-22
公募基金2025年二季报全扫描【国信金工】
葛兰、谢治宇最新持仓曝光:共同聚焦创新药,这些个股被重仓
每经网 · 07-21
葛兰、谢治宇最新持仓曝光:共同聚焦创新药,这些个股被重仓
兴证全球基金谢治宇旗下兴全合宜A中报最新持仓,重仓小米集团-W
证券之星 · 07-20
兴证全球基金谢治宇旗下兴全合宜A中报最新持仓,重仓小米集团-W
诺诚健华:因股份激励计划发行新股总计217.675万股
公司公告 · 07-18
诺诚健华:因股份激励计划发行新股总计217.675万股
诺诚健华07月17日获主力加仓1391.8万元
市场透视 · 07-17
诺诚健华07月17日获主力加仓1391.8万元
每日卖空追踪 | 诺诚健华 07月16日卖空量成交121.3万股,卖空比例为6.98%
市场透视 · 07-16
每日卖空追踪 | 诺诚健华 07月16日卖空量成交121.3万股,卖空比例为6.98%
诺诚健华07月16日获主力加仓673.4万元
市场透视 · 07-16
诺诚健华07月16日获主力加仓673.4万元
创新药概念走势向好 复宏汉霖涨9.72% 机构指板块估值仍具吸引力
金吾财讯 · 07-16
创新药概念走势向好 复宏汉霖涨9.72% 机构指板块估值仍具吸引力
科创成长层改革推进 券商系统升级及风险揭示书签署有序展开
DoNews · 07-16
科创成长层改革推进 券商系统升级及风险揭示书签署有序展开
大佬举牌Biotech龙头
瞪羚社 · 07-15
大佬举牌Biotech龙头
诺诚健华:2023年科创板限制性股票激励计划部分归属期完成股份登记并上市
公司公告 · 07-15
诺诚健华:2023年科创板限制性股票激励计划部分归属期完成股份登记并上市
每日卖空追踪 | 诺诚健华 07月15日卖空量成交291.1万股,卖空比例为9.49%
市场透视 · 07-15
每日卖空追踪 | 诺诚健华 07月15日卖空量成交291.1万股,卖空比例为9.49%
诺诚健华07月15日主力净流入2694.8万元 散户资金抛售
市场透视 · 07-15
诺诚健华07月15日主力净流入2694.8万元 散户资金抛售
医保商保双目录调整 生物医药午后涨幅扩大 荣昌生物涨逾8%
金吾资讯 · 07-15
医保商保双目录调整 生物医药午后涨幅扩大 荣昌生物涨逾8%
港股异动 | 诺诚健华(09969)早盘涨超6% BCL2抑制剂Mesutoclax治疗AML和MDS在美国获批临床
智通财经 · 07-15
港股异动 | 诺诚健华(09969)早盘涨超6% BCL2抑制剂Mesutoclax治疗AML和MDS在美国获批临床
加载更多
公司概况
公司名称:
诺诚健华
所属市场:
SEHK
上市日期:
--
主营业务:
诺诚健华医药有限公司是一家主要从事生物医药研发、生产和商业化的中国公司。该公司专注于肿瘤和自身免疫性疾病等存在巨大未满足临床需求的领域。该公司的主要产品管线包括奥布替尼、Tafasitamab、ICP-490、ICP-B02、ICP-248、ICP-B05、ICP-332、ICP-488、ICP-192、ICP-723、ICP-033和ICP-189等。其产品主要用于治疗血液瘤、实体瘤和自身免疫病。该公司还在开发用于治疗由B细胞或T细胞功能异常所导致的自身免疫性疾病的产品。该公司主要在国内和国外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"09969","market":"HK","secType":"STK","nameCN":"诺诚健华","latestPrice":18.2,"timestamp":1753690152006,"preClose":17.74,"halted":0,"volume":15295342,"delay":0,"floatShares":1495000000,"shares":1763000000,"eps":-0.28436556033535343,"marketStatus":"已收盘","change":0.46,"latestTime":"07-28 16:09:12","open":17.8,"high":18.36,"low":17.3,"amount":273121712,"amplitude":0.059752,"askPrice":18.2,"askSize":29000,"bidPrice":18.18,"bidSize":17000,"shortable":3,"etf":0,"ttmEps":-0.18042338575062017,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753752600000},"marketStatusCode":5,"adr":0,"listingDate":1584892800000,"exchange":"SEHK","adjPreClose":17.74,"openAndCloseTimeList":[[1753666200000,1753675200000],[1753678800000,1753689600000]],"volumeRatio":0.991015,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688428","market":"SH","secType":"STK","nameCN":"诺诚健华","latestPrice":29.88,"timestamp":1753686000000,"preClose":29.48,"halted":0,"volume":6496700,"delay":0,"premium":"-44.31"}},"requestUrl":"/m/hq/s/09969","defaultTab":"news","newsList":[{"id":"2553200528","title":"诺诚健华07月24日主力净流入228.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2553200528","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553200528?lang=zh_cn&edition=full","pubTime":"2025-07-24 16:16","pubTimestamp":1753344962,"startTime":"0","endTime":"0","summary":"07月24日, 诺诚健华股价涨0.90%,报收17.94元,成交金额1.7亿元,换手率0.63%,振幅3.94%,量比0.48。诺诚健华今日主力资金净流入228.3万元,上一交易日主力净流出319.8万元。该股近5个交易日下跌1.32%,主力资金累计净流入605.3万元;近20日主力资金累计净流入2.4亿元,其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724170451a460f06c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724170451a460f06c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09969"],"gpt_icon":0},{"id":"2553219899","title":"诺诚健华07月23日主力净流出319.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2553219899","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553219899?lang=zh_cn&edition=full","pubTime":"2025-07-23 16:15","pubTimestamp":1753258554,"startTime":"0","endTime":"0","summary":"07月23日, 诺诚健华股价跌3.58%,报收17.78元,成交金额4.6亿元,换手率1.72%,振幅5.53%,量比1.46。诺诚健华今日主力资金净流出319.8万元,上一交易日主力净流入70.3万元。该股近5个交易日下跌1.79%,主力资金累计净流入1768.7万元;近20日主力资金累计净流入2.5亿元,其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723170309a6bcee8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723170309a6bcee8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09969","BK1161"],"gpt_icon":0},{"id":"2553575942","title":"券商资管系公募,排名来了!","url":"https://stock-news.laohu8.com/highlight/detail?id=2553575942","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553575942?lang=zh_cn&edition=full","pubTime":"2025-07-23 00:06","pubTimestamp":1753200372,"startTime":"0","endTime":"0","summary":"头部券商资管公募管理规模普遍增长Wind数据显示,截至二季度末,共有4家券商资管机构的公募基金资产管理总规模超千亿元。此外,相比于今年一季度末,头部券商资管的公募管理规模普遍增长,东方红资产管理、华泰证券资管规模增长均超200亿元,招商证券资管规模增长33亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723001401a45cdc20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723001401a45cdc20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01276","688428","688266","06160","ONC","09969","BK0239","06990","688192","688235","600276","688443"],"gpt_icon":0},{"id":"2553236106","title":"诺诚健华07月22日获主力加仓70.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553236106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553236106?lang=zh_cn&edition=full","pubTime":"2025-07-22 16:15","pubTimestamp":1753172138,"startTime":"0","endTime":"0","summary":"07月22日, 诺诚健华股价涨1.43%,报收18.44元,成交金额3.0亿元,换手率1.07%,振幅8.69%,量比0.78。诺诚健华今日主力资金净流入70.3万元,连续6日净流入,上一交易日主力净流入83.0万元。近一年数据显示,该股主力连续6日净流入后,次日上涨概率为33.33%,平均涨幅为1.81%。该股近5个交易日上涨4.47%,主力资金累计净流入2761.8万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入2.6亿元,其中净流入天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722170023a45be4a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722170023a45be4a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09969","BK1161"],"gpt_icon":0},{"id":"2553288748","title":"港股创新药板块异动拉升 丽珠医药涨超12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553288748","media":"E公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553288748?lang=zh_cn&edition=full","pubTime":"2025-07-22 09:53","pubTimestamp":1753149192,"startTime":"0","endTime":"0","summary":"人民财讯7月22日电,港股创新药板块异动拉升,截至发稿,丽珠医药涨超12%,凯莱英涨超6%,诺诚健华涨超4%,君实生物涨超3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722095312a6b9724c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"689392912ea8b05968e2ae0b7e09d3f0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722095312a6b9724c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01513","BK1191","688180","BK1574","06978","06821","01877","HSCEI","09969","BK1161","688428"],"gpt_icon":0},{"id":"2553008144","title":"公募基金2025年二季报全扫描【国信金工】","url":"https://stock-news.laohu8.com/highlight/detail?id=2553008144","media":"量化藏经阁","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553008144?lang=zh_cn&edition=full","pubTime":"2025-07-22 08:06","pubTimestamp":1753142805,"startTime":"0","endTime":"0","summary":"一基金仓位监控在跟踪基金仓位变化时,由于2015年四季度以前股票型基金仓位规定下限为60%,在这之后规定为80%。截至2025年二季报,科技类板块配置权重依旧最高,最新一期配置权重为37.42%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722082610a6b94be8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722082610a6b94be8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600519","688235","YANG","688428","BK4585","BYDDY","ONC","BK4588","09988","BK4099","BK4614","03750","09969","EVS.SI"],"gpt_icon":0},{"id":"2553842793","title":"葛兰、谢治宇最新持仓曝光:共同聚焦创新药,这些个股被重仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2553842793","media":"每经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553842793?lang=zh_cn&edition=full","pubTime":"2025-07-21 16:56","pubTimestamp":1753088193,"startTime":"0","endTime":"0","summary":"另外,兴证全球基金谢治宇管理的兴全合润,二季度减持了比亚迪、海尔智家,转而重仓分众传媒、蓝思科技。葛兰二季度加码创新药先从中欧医疗健康来看,二季度虽然出现净赎回的情况,但整体份额依然超过185亿份,规模超过300亿元。整体来看,创新药行业的持仓个股数量进一步增加,而多只医疗个股、中药个股已不见身影。可以看出,谢治宇二季度也偏爱创新药,重仓了多只个股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721165943a459004f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721165943a459004f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159992","81211","01415","BK0015","688099","600690","688428","01530","BYDDY","03347","688235","BK0028","01801","03750","03759","600160","BK0188","BK0196","09969","BK0044","BK0229","06613","06690","01211"],"gpt_icon":0},{"id":"2552445110","title":"兴证全球基金谢治宇旗下兴全合宜A中报最新持仓,重仓小米集团-W","url":"https://stock-news.laohu8.com/highlight/detail?id=2552445110","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552445110?lang=zh_cn&edition=full","pubTime":"2025-07-20 18:14","pubTimestamp":1753006452,"startTime":"0","endTime":"0","summary":"证券之星消息,7月20日兴证全球基金旗下谢治宇薛怡然管理的兴全合宜灵活配置混合型基金(LOF)公布中报,近1年净值增长率36.12%。与上一季度相比,该基金前十大重仓股新增信达生物,诺诚健华,蓝思科技;其中小米集团-W持仓占比6.28%,为该基金第一大重仓股;高伟电子,腾讯控股,比亚迪股份等退出前十大重仓股;详细数据如下:","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250720182533a456c569&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250720182533a456c569&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359201885.HKD","LU1880383366.USD","LU0345776255.USD","LU0823038988.USD","XIACY","01810","BK1521","LU0611395673.USD","LU1813983027.USD","LU0326950275.SGD","LU0051755006.USD","LU2097828557.USD","BK1618","LU0823413660.USD","LU0039217434.USD","LU0359201612.USD","LU0588546209.SGD","LU1794554557.SGD","LU2097828631.EUR","09969","SG9999002463.SGD","81810","LU1282648689.USD","688428","LU0823397103.USD","LU0164880469.USD","BK1523","BK1589","LU1105468828.SGD","SG9999001093.SGD","MIUmain","LU0320764599.SGD","LU0345775950.USD","LU2152927971.USD","LU0572944931.SGD","LU0149721374.USD","LU0823426480.USD","SG9999003461.SGD","LU0211977185.USD","LU1868837565.USD","LU0918141705.HKD","LU0417516738.SGD","LU0143863784.USD","LU0797268264.HKD","LU2778985437.USD","LU1961090484.USD","LU0348735423.USD","LU0348827113.USD","BK1506","HXXD.SI","BK1607","LU2097828805.USD"],"gpt_icon":0},{"id":"2552501464","title":"诺诚健华:因股份激励计划发行新股总计217.675万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2552501464","media":"公司公告","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552501464?lang=zh_cn&edition=full","pubTime":"2025-07-18 16:55","pubTimestamp":1752828912,"startTime":"0","endTime":"0","summary":"诺诚健华公告,根据2023年人民币股股份激励计划,于2025年7月18日向董事及激励对象发行新股总计217.675万股,每股发行价为RMB6.95,占有关事件前的现有已发行股份比例合计为0.12%,包括首次授予及预留授予部分。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718171431a4531a29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718171431a4531a29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","09969","688428"],"gpt_icon":0},{"id":"2552380964","title":"诺诚健华07月17日获主力加仓1391.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552380964","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552380964?lang=zh_cn&edition=full","pubTime":"2025-07-17 16:15","pubTimestamp":1752740157,"startTime":"0","endTime":"0","summary":"07月17日, 诺诚健华股价涨2.13%,报收18.24元,成交金额4.1亿元,换手率1.51%,振幅5.82%,量比0.73。诺诚健华今日主力资金净流入1391.8万元,连续3日净流入,上一交易日主力净流入673.4万元。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为57.89%,平均涨幅为1.81%。该股近5个交易日上涨31.21%,主力资金累计净流入1.7亿元;近20日主力资金累计净流入2.4亿元,其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717172043a6af70c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717172043a6af70c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09969","BK1161"],"gpt_icon":0},{"id":"2552206124","title":"每日卖空追踪 | 诺诚健华 07月16日卖空量成交121.3万股,卖空比例为6.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552206124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552206124?lang=zh_cn&edition=full","pubTime":"2025-07-16 16:30","pubTimestamp":1752654645,"startTime":"0","endTime":"0","summary":"诺诚健华北京时间07月16日,涨2.29%,卖空量成交121.3万股%,较上一交易日减少82.27%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716173035a6ad23d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716173035a6ad23d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","09969"],"gpt_icon":0},{"id":"2552242031","title":"诺诚健华07月16日获主力加仓673.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552242031","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552242031?lang=zh_cn&edition=full","pubTime":"2025-07-16 16:15","pubTimestamp":1752653745,"startTime":"0","endTime":"0","summary":"07月16日, 诺诚健华股价涨2.29%,报收17.86元,成交金额3.1亿元,换手率1.16%,振幅4.81%,量比0.56。诺诚健华今日主力资金净流入673.4万元,上一交易日主力净流入2694.8万元。|07月16日主力加仓幅度排名||#|股票简称|主力净额占比|#|嘉艺控股|5.11%|#|宜搜科技|2.20%|#|高地股份|1.45%|#|...|...|#253|诺诚健华|0.03%|(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716170544a44e536f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716170544a44e536f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09969"],"gpt_icon":0},{"id":"2551124121","title":"创新药概念走势向好 复宏汉霖涨9.72% 机构指板块估值仍具吸引力","url":"https://stock-news.laohu8.com/highlight/detail?id=2551124121","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551124121?lang=zh_cn&edition=full","pubTime":"2025-07-16 13:41","pubTimestamp":1752644466,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念走势向好,派格生物医药 涨10.83%,复宏汉霖涨9.72%,康方生物涨7.13%,亚盛医药涨4.25%,诺诚健华涨3.5%。对于创新药出海演变方向,该机构观察以下趋势:1)行业进一步衍生出了NewCo等新型交易模式;2)ADC赛道交易兴趣度最高,双抗/多抗、小核酸/mRNA等前沿技术领域亦存在较多机会。基于当前国产创新药资产储备丰富且交易性价比仍显着、MNC存在专利补缺需求、海外投融资边际改善,该机构认为2H25-2026年出海交易热度仍将延续。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716135524a6acadc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716135524a6acadc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09926","BK1574","BK1161","02565","09969","06978","06855","02696"],"gpt_icon":0},{"id":"2551119280","title":"科创成长层改革推进 券商系统升级及风险揭示书签署有序展开","url":"https://stock-news.laohu8.com/highlight/detail?id=2551119280","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551119280?lang=zh_cn&edition=full","pubTime":"2025-07-16 11:13","pubTimestamp":1752635582,"startTime":"0","endTime":"0","summary":"上交所方面正组织风险揭示书签署工作,并修订相关指南,新增《科创板科创成长层企业股票投资风险揭示书必备条款》,明确未盈利企业存在的各类投资风险。上交所下发通知要求券商完善适当性管理工作,包括完成风险揭示书签署及系统准备,给予投资者充分阅读时间,并通过多种渠道开展投资者教育。上交所将持续督促券商并开展监督检查。7月14日,上交所举办专题培训会,120家券商330余名相关负责人参会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071611164495444cb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071611164495444cb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01877","688549","688266","02402","000690.SH","688256","688327","688302","688343","09969","688165","688192","688316","688221","688382","688176","688280","688197","688515","688561","688373","ONC","688702","688443","688512","BK0239","688322","06160","688538","688220","688469","688277","688387"],"gpt_icon":0},{"id":"2551114230","title":"大佬举牌Biotech龙头","url":"https://stock-news.laohu8.com/highlight/detail?id=2551114230","media":"瞪羚社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551114230?lang=zh_cn&edition=full","pubTime":"2025-07-15 20:04","pubTimestamp":1752581040,"startTime":"0","endTime":"0","summary":"上市公司大股东计划通过证券交易所集中竞价交易减持股份,应当在首次卖出的15个交易日前预先披露减持计划。2025年上半年,机构大佬通过举牌方式重仓创新药公司并非只有诺诚健华这一例。此外,其在血液瘤方面目前的王牌应该Bcl-2抑制剂——ICP-248。患者基线上,72.7%的患者为难治性疾病,56.4%的患者既往接受过BTK抑制剂治疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507161248499544615c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507161248499544615c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688428","BK0239","09969"],"gpt_icon":0},{"id":"2551316414","title":"诺诚健华:2023年科创板限制性股票激励计划部分归属期完成股份登记并上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2551316414","media":"公司公告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551316414?lang=zh_cn&edition=full","pubTime":"2025-07-15 19:50","pubTimestamp":1752580234,"startTime":"0","endTime":"0","summary":"诺诚健华公告,公司已完成2023年科创板限制性股票激励计划首次授予部分第二个归属期及预留授予部分第一个归属期的股份登记工作。本次归属涉及138名激励对象,归属股票数量为207.675万股,上市流通日为2025年7月18日。本次归属后,公司已发行股份总数增至176464.395万股,新增股份对公司财务状况和经营成果不构成重大影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715200109a44c5c78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715200109a44c5c78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","688428","09969","BK1161"],"gpt_icon":0},{"id":"2551163594","title":"每日卖空追踪 | 诺诚健华 07月15日卖空量成交291.1万股,卖空比例为9.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551163594","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551163594?lang=zh_cn&edition=full","pubTime":"2025-07-15 16:30","pubTimestamp":1752568239,"startTime":"0","endTime":"0","summary":"诺诚健华北京时间07月15日,涨6.46%,卖空量成交291.1万股%,较上一交易日减少54.85%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715172908a44c0339&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715172908a44c0339&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK1161","BK1574"],"gpt_icon":0},{"id":"2551266169","title":"诺诚健华07月15日主力净流入2694.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2551266169","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551266169?lang=zh_cn&edition=full","pubTime":"2025-07-15 16:15","pubTimestamp":1752567332,"startTime":"0","endTime":"0","summary":"07月15日, 诺诚健华股价涨6.46%,报收17.46元,成交金额5.3亿元,换手率2.05%,振幅9.02%,量比1.14。诺诚健华今日主力资金净流入2694.8万元,上一交易日主力净流出1596.5万元。该股近5个交易日上涨33.44%,主力资金累计净流入1.8亿元;近20日主力资金累计净流入2.1亿元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715165030a44be629&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715165030a44be629&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK1161","BK1574"],"gpt_icon":0},{"id":"2551156152","title":"医保商保双目录调整 生物医药午后涨幅扩大 荣昌生物涨逾8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551156152","media":"金吾资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551156152?lang=zh_cn&edition=full","pubTime":"2025-07-15 14:18","pubTimestamp":1752560315,"startTime":"0","endTime":"0","summary":"截至发稿,荣昌生物涨8.37%,石药集团涨7.26%,诺诚健华涨6.95%,百济神州涨6.43%,中国生物制药涨4.61%,信达生物涨3.66%。消息面上,2025年国家基本医疗保险,生育保险和工伤保险药品目录及商业健康保险创新药品目录调整7月11日正式启动。世纪证券指出,创新药商保目录意味着国内医药多元支付体系重构,商业健康险将在创新药支付方面扮演更为重要的角色,高价创新药可及性有望进一步提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071514191497a6a43d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071514191497a6a43d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0008369823.USD","BK1583","LU1226288170.HKD","SG9999004220.SGD","IE00BZ08YR35.GBP","LU0501845795.SGD","IE00BZ08YT58.USD","BK1515","LU0140636845.USD","LU1226287792.SGD","09969","IE00BZ08YS42.EUR","01801","LU1969619763.USD","SBHMY","LU1951186391.HKD","LU0326950275.SGD","LU0072913022.USD","LU1152091168.USD","IE00B5MMRT66.SGD","LU1807302812.USD","688428","BK1191","688235","688331","LU0880133367.SGD","09995","LU0067412154.USD","01093","06160","BK1161","IE00B031HY20.USD","LU1008478684.HKD","LU1993786604.SGD","BK1574","01177","LU1226287529.USD","IE0008368742.USD","LU1226288253.USD","LU1226287875.USD","BK1521","LU1960683339.HKD","LU2328871848.SGD","LU1152091754.HKD","ONC","IE00B543WZ88.USD","LU0315179316.USD"],"gpt_icon":0},{"id":"2551130044","title":"港股异动 | 诺诚健华(09969)早盘涨超6% BCL2抑制剂Mesutoclax治疗AML和MDS在美国获批临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2551130044","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551130044?lang=zh_cn&edition=full","pubTime":"2025-07-15 11:14","pubTimestamp":1752549242,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,诺诚健华早盘涨超6%,截至发稿,涨5.24%,报17.26港元,成交额1.94亿港元。消息面上,诺诚健华宣布,公司自主研发的新型BCL2抑制剂mesutoclax联合阿扎胞苷治疗髓系恶性肿瘤,包括急性髓系白血病和骨髓增生异常综合征,已获得美国食品药品监督管理局批准开展临床研究。Mesutoclax通过选择性地抑制BCL2,恢复肿瘤细胞程序性死亡机制,从而发挥抗肿瘤疗效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1317801.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK1574","09969","BK1161","688428"],"gpt_icon":0}],"profile":{"websiteUrl":"https://cn.innocarepharma.com","stockEarnings":[{"period":"1week","weight":-0.0493},{"period":"1month","weight":0.2892},{"period":"3month","weight":0.7495},{"period":"6month","weight":2.1232},{"period":"1year","weight":2.9422},{"period":"ytd","weight":1.8987}],"compareEarnings":[{"period":"1week","weight":0.0227},{"period":"1month","weight":0.0373},{"period":"3month","weight":0.155},{"period":"6month","weight":0.2652},{"period":"1year","weight":0.493},{"period":"ytd","weight":0.2656}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"诺诚健华医药有限公司是一家主要从事生物医药研发、生产和商业化的中国公司。该公司专注于肿瘤和自身免疫性疾病等存在巨大未满足临床需求的领域。该公司的主要产品管线包括奥布替尼、Tafasitamab、ICP-490、ICP-B02、ICP-248、ICP-B05、ICP-332、ICP-488、ICP-192、ICP-723、ICP-033和ICP-189等。其产品主要用于治疗血液瘤、实体瘤和自身免疫病。该公司还在开发用于治疗由B细胞或T细胞功能异常所导致的自身免疫性疾病的产品。该公司主要在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.115368},{"month":2,"riseRate":0.6,"avgChangeRate":0.148393},{"month":3,"riseRate":0,"avgChangeRate":-0.036551},{"month":4,"riseRate":0.666667,"avgChangeRate":0.116223},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.042592},{"month":6,"riseRate":0.833333,"avgChangeRate":0.12939},{"month":7,"riseRate":0.5,"avgChangeRate":0.035696},{"month":8,"riseRate":0.2,"avgChangeRate":-0.086099},{"month":9,"riseRate":0.2,"avgChangeRate":-0.051427},{"month":10,"riseRate":0.4,"avgChangeRate":0.007797},{"month":11,"riseRate":0.8,"avgChangeRate":0.112999},{"month":12,"riseRate":0.6,"avgChangeRate":0.018835}],"exchange":"SEHK","name":"诺诚健华","nameEN":"INNOCARE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺诚健华(09969)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺诚健华(09969)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺诚健华,09969,诺诚健华股票,诺诚健华股票老虎,诺诚健华股票老虎国际,诺诚健华行情,诺诚健华股票行情,诺诚健华股价,诺诚健华股市,诺诚健华股票价格,诺诚健华股票交易,诺诚健华股票购买,诺诚健华股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺诚健华(09969)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺诚健华(09969)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}